Alcohol and Alcoholism Advance Access published online on December 15, 2006
Alcohol and Alcoholism, doi:10.1093/alcalc/agl091
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 No. 207, 5340 Plymouth Road, Ann Arbor, MI 48105, USA
* To whom correspondence should be addressed. Aims: To further test whether the baclofen-induced suppression of motivation to consume alcohol in animals could be transposed to humans. Methods: A patient who had neither tolerated nor benefited from other alcohol treatment modalities was put on trial with baclofen on a dosage up to 140 mg/day. Results: The patient reported dramatic reduction in cravings for and preoccupation with alcohol. Conclusions: High-dose baclofen therapy was associated with complete and prolonged suppression of symptoms and consequences of alcohol-dependence.
Received July 14, 2006
Revised August 18, 2006
Accepted September 5, 2006
Case Report
SUPPRESSION OF SYMPTOMS OF ALCOHOL DEPENDENCE AND CRAVING USING HIGH-DOSE BACLOFEN
WILLIAM BUCKNAM 1 *
WILLIAM BUCKNAM, E-mail: wbucknam{at}hotmail.com
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Leggio Understanding and Treating Alcohol Craving and Dependence: Recent Pharmacological and Neuroendocrinological Findings Alcohol Alcohol., July 1, 2009; 44(4): 341 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ameisen Gamma-Hydroxybutyrate (GHB)-Deficiency in alcohol-dependence? Alcohol Alcohol., September 1, 2007; 42(5): 506 - 506. [Full Text] [PDF] |
||||
